Skip to main content
. 2021 Jan 26;16:651–665. doi: 10.2147/IJN.S290444

Table 1.

Preliminary Screening of Mixed Polymeric Micellar Formulations with Various Ratios of Different Amphiphiles (NaDOC, PP123, PF68, PF87, PF127, PF108, and PL121, CRH40 and CELP) and Lecithin

Amphiphile (HLB) H/M:Lecithin:Amphiphile
1:0:5 1:1:5 1:0:10 1:1:10 1:0:20 1:1:20
NaDOC (16) 1300.6 ± 316.48a,c
(1.177 ± 0.832)b
227.8 ± 45.86 (0.631 ± 0.238) 169.6 ± 152.14 (5.877 ± 11.17) 215.7 ± 131.03 (1.211 ± 0.289) 234.7 ± 152.33 (0.456 ± 1.385) 636.3 ± 286.29 (0.035 ± 0.97)
PF68 (>24) 346.2 ± 8.48 (0.091 ± 0.124) 986.9 ± 484.23 (1.461 ± 0.068) 105.6 ± 5.91 (0.129 ± 0.041) 641.5 ± 5.39 (0.495 ± 0.149) 103.9 ± 6.35 (1.26 ± 0.335) 448.2 ± 26.41 (0.655 ± 0.066)
PF108 (>24) 29.9 ± 3.11 (0.675 ± 0.159) 746.7 ± 50.79 (0.603 ± 0.139) 35.1 ± 3.16 (0.762 ± 0.364) 392.7 ± 11.01 (0.546 ± 0.067) 30.2 ± 5.16 (0.725 ± 0.364) 253.9 ± 3.14 (0.466 ± 0.1)
PF87 (>24) 21.8 ± 6.42 (0.275 ± 1.492) 701.1 ± 134.1 (0.816 ± 0.258) 191.3 ± 126.22 (23.08 ± 33.43) 882.2 ± 14.06 (0.211 ± 0.099) 28.4 ± 6.31 (2.124 ± 0.488) 1054 ± 267.64 (0.033 ± 1.068)
PF127 (18–23) 30.9 ± 2.73 (0.558 ± 0.364) 2243 ± 1819 (1.313 ± 0.258) 29.2 ± 1.6 (1.26 ± 0.35) 772.5 ± 101.9 (1.51 ± 0.07) 47.7 ± 47.9 (1.379 ± 1.508) 854.6 ± 336.8 (1.621±0.068)
PL121 (1–7) ≥3000 ≥3000 ≥3000 ≥3000 ≥3000 ≥3000
PP123 (7–9) 1181.6 ± 51.21 (1.305 ± 0.028) 371.7 ± 12.77 (1.033 ± 0.016) 120.3 ± 9.87 (0.343 ± 0.297) 149.2 ± 1.49 (0.686 ± 0.037) 122.9 ± 5.89 (0.552 ± 0.091) 100 ± 7.12 (0.899 ± 0.062)
CRH40 (14.3) 198.6 ± 0.88 (0.466 ± 0.022) 256.3 ± 7.54 (0.87 ± 0.039) 115 ± 1.42 (1.203 ± 0.063) 348.6 ± 2.75 (1.044 ± 0.064) 28.2 ± 14.29 (0.976 ± 3.515) 322.4 ± 17.37 (1.969 ± 0.026)
CELP (13.9) 164.6 ± 1.57 (0.755 ± 0.01) 235 ± 3.24
(0.758 ± 0.029)
20.3±1.03 (0.862 ± 0.634) 302.5 ± 8.194 (1.298 ± 0.042) 16.2 ± 6.45 (1.044 ± 0.273) 98.6 ± 11.15 (1.591 ± 0.101)

Notes: aMean size±standard deviation (SD). bMean polydispersity index±SD. cUnderlining indicates precipitation during 12 h.

Abbreviations: H/M, honokiol-magnolol; HLB, hydrophilic-lipophilic balance.